retatrutide weight loss phase 2 trial results with as compared to currently licenced obesity Difference between tirzepatide and retatrutide:

In TRIUMPH-4, retatrutide showed higher GI rates (nausea 43% vs 31%, vomiting 21% vs 12%)

People taking Contrave for weight loss should be monitored for the development of psychiatric side effects, including depression, mania, psychosis, hallucinations, paranoia, delusions, homicidal ideation, hostility, aggression, anxiety, panic, and agitationin addition to suicidal thoughts and behaviors mentioned above

Dosing convenience, oral versus injectable formulation, side effect profiles, and insurance coverage will create room for multiple products

Aviles-Olmos I & Kefalopoulou Z (2012) Aviles-Olmos I, Kefalopoulou Z, Djamshidian A, Limousin P, Dickson J, Lees A, et al

He is the founder of the Boston Healthcare Cloud & AI Community and speaks globally on responsible AI adoption in healthcare.